Gene · 2532
Papers3,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Heterodimers Are an Integral Component of Chemokine Signaling Repertoire. | Int J Mol Sci | 2023 | 37511398 | PubTator, text mining | PubMed |
| Identification of TGF-β-related genes in cardiac hypertrophy and heart failure based on single cell RNA sequencing. | Aging (Albany NY) | 2023 | 37498303 | PubTator, text mining | PubMed |
| High throughput human genotyping for variants associated with malarial disease outcomes using custom targeted amplicon sequencing. | Sci Rep | 2023 | 37495620 | PubTator, text mining | PubMed |
| Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer. | Nat Cancer | 2023 | 37488416 | PubTator, text mining | PubMed |
| The activity of cuproptosis pathway calculated by AUCell algorithm was employed to construct cuproptosis landscape in lung adenocarcinoma. | Discov Oncol | 2023 | 37481739 | PubTator, text mining | PubMed |
| Designing an effective malaria vaccine targeting Plasmodium vivax Duffy-binding protein. | Trends Parasitol | 2023 | 37481347 | PubTator, text mining | PubMed |
| Single-Cell Characterization of Pulmonary Nodules Implicates Suppression of Immunosurveillance across Early Stages of Lung Adenocarcinoma. | Cancer Res | 2023 | 37477508 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis reveals the clinical implications of myeloid-derived suppressor cells in head and neck squamous cell carcinoma. | Pathol Oncol Res | 2023 | 37475874 | PubTator, text mining | PubMed |
| Prevalence and distribution of Plasmodium vivax Duffy Binding Protein gene duplications in Sudan. | PLoS One | 2023 | 37471337 | PubTator, text mining | PubMed |
| Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection. | Nat Commun | 2023 | 37468466 | PubTator, text mining | PubMed |
| TNF superfamily control of tissue remodeling and fibrosis. | Front Immunol | 2023 | 37465675 | PubTator, text mining | PubMed |
| Vascular endothelial profilin-1 drives a protumorigenic tumor microenvironment and tumor progression in renal cancer. | J Biol Chem | 2023 | 37451478 | PubTator, text mining | PubMed |
| Immunoregulatory effects of Huaier (Trametes robiniophila Murr) and relevant clinical applications. | Front Immunol | 2023 | 37449208 | PubTator, text mining | PubMed |
| Chemokine Heteromers and Their Impact on Cellular Function-A Conceptual Framework. | Int J Mol Sci | 2023 | 37446102 | PubTator, text mining | PubMed |
| Beyond the Complement Cascade: Insights into Systemic Immunosenescence and Inflammaging in Age-Related Macular Degeneration and Current Barriers to Treatment. | Cells | 2023 | 37443742 | PubTator, text mining | PubMed |
| Angiocrine Signaling in Sinusoidal Health and Disease. | Semin Liver Dis | 2023 | 37442155 | PubTator, text mining | PubMed |
| Brief literature review and comprehensive bioinformatics analytics unravel the potential mechanism of curcumin in the treatment of periodontitis. | BMC Oral Health | 2023 | 37422651 | PubTator, text mining | PubMed |
| Optimal strategies for learning multi-ancestry polygenic scores vary across traits. | Nat Commun | 2023 | 37419925 | PubTator, text mining | PubMed |
| The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers. | Cells | 2023 | 37408240 | PubTator, text mining | PubMed |
| Study on the mechanism of action of colchicine in the treatment of coronary artery disease based on network pharmacology and molecular docking technology. | Front Pharmacol | 2023 | 37405052 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2532/papers?page=18